Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 22.66% vs 8.39% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 66.00% vs 18.39% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 46.53% vs 9.46% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 59.09% vs -77.08% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Anuh Pharma With
Figures in Rs cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
647.00
8,558.51
-7,911.51
-92.44%
Other Operating Income
0.00
0.00
0.00
Total Operating income
647.00
8,558.51
-7,911.51
-92.44%
Raw Material Cost
489.73
859.11
-369.38
-43.00%
Purchase of Finished goods
12.18
1,825.86
-1,813.68
-99.33%
(Increase) / Decrease In Stocks
-15.24
-60.74
45.50
74.91%
Employee Cost
19.39
1,890.84
-1,871.45
-98.97%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
65.81
1,859.00
-1,793.19
-96.46%
Total Expenditure (Excl Depreciation)
571.86
6,374.07
-5,802.21
-91.03%
Operating Profit (PBDIT) excl Other Income
75.14
2,184.44
-2,109.30
-96.56%
Other Income
12.10
266.64
-254.54
-95.46%
Operating Profit (PBDIT)
87.24
2,451.08
-2,363.84
-96.44%
Interest
0.35
14.57
-14.22
-97.60%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
86.89
2,436.51
-2,349.62
-96.43%
Depreciation
8.58
317.46
-308.88
-97.30%
Profit Before Tax
78.31
2,119.05
-2,040.74
-96.30%
Tax
18.25
399.17
-380.92
-95.43%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
60.06
1,719.88
-1,659.82
-96.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
60.06
1,823.41
-1,763.35
-96.71%
Equity Capital
25.06
40.06
-15.00
-37.44%
Face Value
5.00
1.00
0.00
Reserves
266.16
9,583.75
-9,317.59
-97.22%
Earnings per share (EPS)
11.98
45.52
-33.54
-73.68%
Diluted Earnings per share
11.98
45.45
-33.47
-73.64%
Operating Profit Margin (Excl OI)
11.61%
25.52%
0.00
-13.91%
Gross Profit Margin
13.43%
28.47%
0.00
-15.04%
PAT Margin
9.28%
20.10%
0.00
-10.82%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 647.00 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 22.66% vs 8.39% in Mar 2023
Annual - Standalone Net Profit
Standalone Net Profit 60.06 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 66.00% vs 18.39% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.14 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 46.53% vs 9.46% in Mar 2023
Annual - Interest
Interest 0.35 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 59.09% vs -77.08% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.61%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023